Drug does not improve outcomes for patients with advanced heart failure

Among patients recently hospitalized with heart failure and reduced left ventricular ejection fraction (LVEF; a measure of heart function), the use of the drug liraglutide did not lead to greater post-hospitalization clinical stability, according to a new study.